


Searching News Database: NM100060
HSMN NewsFeed - 31 Jan 2007
NexMed Announces Patient Dosing in Phase 3 Program for Anti-Fungal Product
NexMed Announces Patient Dosing in Phase 3 Program for Anti-Fungal Product
HSMN NewsFeed - 26 Jun 2006
NexMed Announces Termination of Alprox-TD Agreement With Schering AG and Provides Operational Update
NexMed Announces Termination of Alprox-TD Agreement With Schering AG and Provides Operational Update
Additional items found! 1
Members Archive contains
1 additional stories matching:
NM100060
(Password required)
NM100060
(Password required)
